Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18254722rdf:typepubmed:Citationlld:pubmed
pubmed-article:18254722lifeskim:mentionsumls-concept:C0019693lld:lifeskim
pubmed-article:18254722lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18254722lifeskim:mentionsumls-concept:C0389071lld:lifeskim
pubmed-article:18254722lifeskim:mentionsumls-concept:C0597298lld:lifeskim
pubmed-article:18254722lifeskim:mentionsumls-concept:C0184511lld:lifeskim
pubmed-article:18254722lifeskim:mentionsumls-concept:C0289313lld:lifeskim
pubmed-article:18254722lifeskim:mentionsumls-concept:C0920563lld:lifeskim
pubmed-article:18254722pubmed:issue6lld:pubmed
pubmed-article:18254722pubmed:dateCreated2008-8-11lld:pubmed
pubmed-article:18254722pubmed:abstractTextThe present study was designed to investigate the relationship of isoforms of adiponectin to insulin sensitivity in subjects with HIV-associated insulin resistance in response to treatment with the thiazolidinedione, rosiglitazone. The two isoforms of adiponectin, HMW (high-molecular-mass) and LMW (low-molecular-mass), were separated by sucrose-gradient-density centrifugation. The amount of adiponectin in gradient fractions was determined by ELISA. Peripheral insulin sensitivity (Rd) was determined with hyperinsulinaemic-euglycaemic clamp, whereas hepatic sensitivity [HOMA (Homoeostasis Model Assessment) %S] was based on basal glucose and insulin values. Treatment with rosiglitazone for 3 months resulted in a significant improvement in the index of hepatic insulin sensitivity (86.4+/-15% compared with 139+/-23; P=0.007) as well as peripheral insulin sensitivity (4.04+/-0.23 compared with 6.17+/-0.66 mg of glucose/kg of lean body mass per min; P<0.001). Improvement in HOMA was associated with increased levels of HMW adiponectin (r=0.541, P=0.045), but not LMW adiponectin. The present study suggests that the HMW isoform of adiponectin is important in the regulation of rosiglitazone-mediated improvement in insulin sensitivity in individuals with HIV-associated insulin resistance, particularly in the liver.lld:pubmed
pubmed-article:18254722pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18254722pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18254722pubmed:languageenglld:pubmed
pubmed-article:18254722pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18254722pubmed:citationSubsetIMlld:pubmed
pubmed-article:18254722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18254722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18254722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18254722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18254722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18254722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18254722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18254722pubmed:statusMEDLINElld:pubmed
pubmed-article:18254722pubmed:monthSeplld:pubmed
pubmed-article:18254722pubmed:issn1470-8736lld:pubmed
pubmed-article:18254722pubmed:authorpubmed-author:GelatoMarie...lld:pubmed
pubmed-article:18254722pubmed:authorpubmed-author:McNurlanMarga...lld:pubmed
pubmed-article:18254722pubmed:authorpubmed-author:AhnHongshikHlld:pubmed
pubmed-article:18254722pubmed:authorpubmed-author:FerrisRobertRlld:pubmed
pubmed-article:18254722pubmed:authorpubmed-author:MynarcikDenni...lld:pubmed
pubmed-article:18254722pubmed:authorpubmed-author:QurashiSaimaSlld:pubmed
pubmed-article:18254722pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18254722pubmed:volume115lld:pubmed
pubmed-article:18254722pubmed:ownerNLMlld:pubmed
pubmed-article:18254722pubmed:authorsCompleteYlld:pubmed
pubmed-article:18254722pubmed:pagination197-202lld:pubmed
pubmed-article:18254722pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:meshHeadingpubmed-meshheading:18254722...lld:pubmed
pubmed-article:18254722pubmed:year2008lld:pubmed
pubmed-article:18254722pubmed:articleTitleImportance of the high-molecular-mass isoform of adiponectin in improved insulin sensitivity with rosiglitazone treatment in HIV disease.lld:pubmed
pubmed-article:18254722pubmed:affiliationDepartment of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.lld:pubmed
pubmed-article:18254722pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18254722pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:18254722pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed